Post by World Journal of Urology EB

📢 New in the World Journal of Urology Hereditary kidney cancer syndromes require specialized, multidisciplinary care, yet evidence-based guidance for clinical practice remains limited. “What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group” provides a comprehensive overview of the current evidence and practical recommendations for the management of renal cell carcinoma in patients with Von Hippel-Lindau (VHL) syndrome. The review discusses: 🔹 Clinical recognition and genetic evaluation of VHL syndrome 🔹 Imaging and surveillance strategies for renal lesions 🔹 The role of nephron-sparing surgery in preserving lifelong kidney function 🔹 Emerging minimally invasive and focal treatment options 🔹 The evolving role of HIF-2α inhibition with belzutifan 🔹 The importance of multidisciplinary care in specialized centers Developed by an international panel of experts from the EAU Young Academic Urologists (YAU) Renal Cancer Working Group, this article offers practical insights to support clinicians caring for patients with this rare hereditary cancer syndrome. Read the full article in the World Journal of Urology. https://lnkd.in/eRQNDGVa #Urology #RenalCellCarcinoma #KidneyCancer #VonHippelLindau #VHL #EAU #Genetics Selcuk Erdem Daniele Amparore Chiara Re Samed Verep Umberto Capitanio Alessandro Larcher Eduard Roussel Tobias Klatte Riccardo Giuseppe Bertolo Nicola Pavan Önder Kara Alexandre Ingels Angela Pecoraro Michele Marchioni Savio Domenico Pandolfo Pietro Diana Umberto Carbonara Veronica Mollica Leonardo Borregales Laura Marandino Gopal Sharma Anna Calio Zhenjie Wu Giuseppe R. Carme Mir Riccardo Campi European Association of Urology